Literature DB >> 7352436

Serum 1,25-dihydroxyvitamin D levels in normal children and in vitamin D disorders.

R W Chesney, J F Rosen, A J Hamstra, H F DeLuca.   

Abstract

Using a precise assay for 1,25-dihydroxyvitamin D in serum, the levels in 103 children, aged 13 months to 16 years, were found to be 43 +/- 2 pg/mL (mean +/- SE). This value is higher than reported values in adults and in neonates. Age-related changes in 1,25-dihydroxyvitamin D levels during childhood were also evident. Older children have significantly higher levels than children less than 11 years, possibly indicating changes with puberty and the adolescent growth spurt. The values were significantly reduced in childhood uremia (13 +/- 5 pg/mL), in hypoparathyroidism (16 +/- 1 pg/mL), and in children with Fanconi's syndrome. Treatment with oral calcitriol in these three groups of patients led to increased serum levels.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7352436     DOI: 10.1001/archpedi.1980.02130140009004

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  14 in total

Review 1.  Molecular genetics of mineral metabolic disorders.

Authors:  R V Thakker
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  Serum vitamin D metabolites are not related to growth rate, bone mineral content, or serum alkaline phosphatase in male puberty.

Authors:  S Krabbe; C Christiansen; L Hummer
Journal:  Calcif Tissue Int       Date:  1986-03       Impact factor: 4.333

3.  The receptor-dependent actions of 1,25-dihydroxyvitamin D are required for normal growth plate maturation in NPt2a knockout mice.

Authors:  Susanne U Miedlich; Eric D Zhu; Yves Sabbagh; Marie B Demay
Journal:  Endocrinology       Date:  2010-08-04       Impact factor: 4.736

4.  Mechanism for bone disease found in inhabitants environmentally exposed to cadmium: decreased serum 1 alpha, 25-dihydroxyvitamin D level.

Authors:  K Nogawa; I Tsuritani; T Kido; R Honda; Y Yamada; M Ishizaki
Journal:  Int Arch Occup Environ Health       Date:  1987       Impact factor: 3.015

5.  Demonstration that circulating 1 alpha, 25-dihydroxyvitamin D is loosely regulated in normal children.

Authors:  P H Stern; A B Taylor; N H Bell; S Epstein
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

6.  Serum 1,25-dihydroxyvitamin D levels in subjects with X-linked hypophosphatemic rickets and osteomalacia.

Authors:  K W Lyles; A G Clark; M K Drezner
Journal:  Calcif Tissue Int       Date:  1982-03       Impact factor: 4.333

7.  Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.

Authors:  A A Portale; B E Booth; B P Halloran; R C Morris
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

8.  Local action of phosphate depletion and insulin-like growth factor 1 on in vitro production of 1,25-dihydroxyvitamin D by cultured mammalian kidney cells.

Authors:  L Condamine; C Menaa; F Vrtovsnik; F Vztovsnik; G Friedlander; M Garabédian
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

9.  Decrease in bone levels of 1,25-dihydroxyvitamin D in women with subcapital fracture of the femur.

Authors:  C Lidor; P Sagiv; B Amdur; R Gepstein; I Otremski; T Hallel; S Edelstein
Journal:  Calcif Tissue Int       Date:  1993-02       Impact factor: 4.333

Review 10.  Molecular biology of hypophosphataemic rickets and oncogenic osteomalacia.

Authors:  P S Rowe
Journal:  Hum Genet       Date:  1994-11       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.